SY - Tanggungan utang jangka dawa perusahaan SoYoung

Logo perusahaan publik So-Young Corp (SY)

The market dynamics of So-Young International (SY) securities demonstrate a long-term debt structure that currently stands at 0.03. The business leverages the network advantage of China's largest IT service in the aesthetics sector, which hinders competitor expansion despite strict oversight from the PRC. A decline in consumer demand and stringent advertising controls act as constraining factors. However, the implementation of AI algorithms makes clinic selection transparent, thereby modernizing the industry.

Utang jangka dawa perusahaan: SoYoung (SY) kanggo 04.07.2022 - 31.10.2026
Barang utama So-Young International Inc.

So-Young International (SY) leadership in Asian medtech requires constant investment to defend against the expansion of super-apps. The analysis of the company's long-term debt is based on the total sum of all credit obligations with a maturity of more than one year. This price action reflects the balance between financial leverage and the issuer's solvency. A steady reduction in the debt load confirms the resilience of the business model and enhances the asset's investment attractiveness.

Analisis pesaing So-Young International

veeva.com (VEEV) - Utang jangka dawa|Doximity - Utang jangka dawa perusahaan|HQY (HealthEquity Inc) - Tanggungan utang jangka dawa perusahaan|Waystar Inc. (WAY) - Utang jangka dawa perusahaan|CRVL - Gunggunge utang jangka dawa|Utang jangka dawa perusahaan Privia Health Group|Utang jangka dawa huronconsultinggroup.com HURN|Kewajiban jangka dawa perusahaan CERT (Certara)|Omnicell Inc (OMCL) - Tanggungan jangka dawa|GoodRx Corp - Kewajiban jangka dawa perusahaan|Schrodinger Corp (SDGR) - Utang jangka dawa|PHR - Utang jangka dawa perusahaan|Utang jangka dawa omadahealth.com|EVH (Evolent Health) - Kewajiban jangka dawa perusahaan|HealthStream Inc (HSTM) - Utang jangka dawa perusahaan|Utang jangka dawa perusahaan Definitive Healthcare Inc.|Tanggungan utang jangka dawa perusahaan CCSI (Consensus Corp)|Utang jangka dawa perusahaan AGL|absci.com (ABSI) - Tanggungan jangka dawa|National Research Corp - Kewajiban jangka dawa perusahaan|Silihan lan utang jangka dawa perusahaan SPOK|OptimizeRx Corp. - Utang jangka dawa perusahaan|Gunggunge utang jangka dawa TruBridge Corp TBRG|Simulations Plus, Inc. (SLP) - Utang jangka dawa perusahaan|Tanggungan utang jangka dawa perusahaan SOPH|Kewajiban jangka dawa perusahaan HCAT|CCLD (CareCloud Corp) - Gedhene kewajiban jangka dawa|Utang jangka dawa perusahaan RSSS|DLHC - Utang jangka dawa|Utang jangka dawa perusahaan OneMedNet ONMD|Silihan lan utang jangka dawa perusahaan SCNX|HCTI - Utang jangka dawa perusahaan|ISPC (iSpecimen Inc.) - Tanggungan utang jangka dawa perusahaan|BFRG: Utang jangka dawa perusahaan|SCWorx Inc (WORX) - Utang jangka dawa perusahaan|Kewajiban jangka dawa perusahaan MSPR|ICCT (iCoreConnect Corp) - Gedhene kewajiban jangka dawa|Utang jangka dawa perusahaan MEDS|Gunggunge utang jangka dawa Orgenesis Inc|Utang jangka dawa perusahaan R1 RCM RCM|Sharecare Inc (SHCR) - Utang jangka dawa|STRM - Utang jangka dawa perusahaan|SYRA (syrahealth.com) - Tanggungan utang jangka dawa perusahaan|AMEH: Utang jangka dawa perusahaan|Model N Inc (MODN) - Utang jangka dawa perusahaan|Utang jangka dawa perusahaan NextGen